AA
TMO icon

Auxano Advisors’s Thermo Fisher Scientific TMO Stock Holding History

Auxano Advisors’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$212K Sell
422
-72
-15% -$34.6K 0.04% 197
2026
Q1 		$243K Sell
494
-21
-4% -$11.4K 0.05% 176
2025
Q4 		$298K Buy
515
+83
+19% +$46.9K 0.06% 153
2025
Q3 		$210K Buy
+432
New +$201K 0.04% 167
2025
Q2 		– Sell
-538
Closed -$268K – 168
2025
Q1 		$268K Buy
538
+47
+10% +$25.5K 0.07% 133
2024
Q4 		$255K Sell
491
-30
-6% -$16.5K 0.06% 140
2024
Q3 		$322K Hold
521
– – 0.08% 121
2024
Q2 		$288K Buy
521
+21
+4% +$12K 0.08% 123
2024
Q1 		$291K Buy
500
+119
+31% +$66.8K 0.08% 125
2023
Q4 		$202K Buy
+381
New +$184K 0.07% 127
2023
Q3 		– Sell
-380
Closed -$219K – 105
2023
Q2 		$219K Hold
380
– – 0.09% 97
2023
Q1 		$219K Hold
380
– – 0.09% 97
2022
Q4 		$209K Buy
+380
New +$201K 0.09% 92

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Auxano Advisors's TMO Position: Q2 2026 in Review

Auxano Advisors reduced its Thermo Fisher Scientific (TMO) stake by 15% in Q2 2026, selling an estimated $34.6K and leaving 422 shares worth $212K. The position accounts for 0.04% of the portfolio, ranked #197.

Auxano Advisors first reported a position in TMO in Q4 2022 and has held it in 13 quarters since. The position peaked at $322K in Q3 2024. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Auxano Advisors held 422 shares of Thermo Fisher Scientific worth $212K as of Q2 2026.
  • Auxano Advisors sold 72 Thermo Fisher Scientific shares in Q2 2026, an estimated $34.6K.
  • Thermo Fisher Scientific made up 0.04% of Auxano Advisors's portfolio in Q2 2026, its #197 holding.
  • Auxano Advisors first reported a position in Thermo Fisher Scientific in Q4 2022 and has held it in 13 quarters since.
  • Auxano Advisors's Thermo Fisher Scientific position peaked at $322K in Q3 2024.
  • 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Auxano Advisors's 13F filing for Q2 2026, filed 7 Aug 2026.